Company ProfilePremium

Troy Corporation

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Troy Corporation - Company showcase

Year Founded & Workforce

1950

650 Employees

Troy Corporation logo

Troy Corporation Employee Contacts

9 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Troy Corporation Overview

Troy Corporation is one of the original American specialists in industrial microbial control. For more than seven decades it built a niche franchise in preservatives and performance additives that protect paints, coatings, building materials, wood, plastics, textiles, metalworking fluids and personal care products from microbial spoilage and fungal or algal defacement. Its defining technical legacy is the invention of IPBC (3-iodo-2-propynyl butyl carbamate), now one of the world's most widely used dry-film fungicides. It sold IPBC under the Polyphase brand alongside the Mergal wet-state preservative family and a broad additives line (Troykyd defoamers, Troysol wetting agents, Troysperse dispersants, Troythix rheology modifiers, Troymax/Troychem driers). The 2015 purchase of Ashland's industrial biocides assets added the Fungitrol and Nuosept brands. Since January 2022 Troy has formed the dry-film and architectural-coatings core of Arxada's Microbial Control Solutions franchise. That gives it a much larger balance sheet and active-ingredient portfolio, but it also exposes the business to the parent's leveraged capital structure, which was restructured in 2026.


What the company does

Troy develops, registers, manufactures and sells specialty chemicals in three broad families:

  1. Preservatives / biocides (microbial control)

    • Dry-film preservatives, which protect a cured coating, sealant or building product from mould, mildew and algae after application (Polyphase, Fungitrol, Troysan).

    • Wet-state (in-can) preservatives, which protect water-based products from bacterial and fungal spoilage in the container (Mergal, Nuosept).

    • Metalworking fluid (MWF) bactericides and fungicides, together with microbial contamination test kits.

    • Industrial disinfectants and microbial detection kits.

  2. Performance additives for liquid and powder coatings, inks and adhesives: defoamers, substrate-wetting, flow and levelling agents, dispersants, rheology modifiers and powder-coating additives.

  3. Metal carboxylates, meaning driers, anti-skinning agents and urethane catalysts for oxidatively curing coatings and some lubricant applications.

Aggregator profiles describe the range as fungicides, algaecides, dispersants, defoamers, bactericides, wetting agents, rheology modifiers, flow and levelling agents, microbial detection kits, industrial disinfectants, powder coating additives, driers and urethane catalysts (Craft company summary). Lubes'n'Greases (November 2021) reported that Troy produced more than 400 preservatives, performance additives and metal carboxylates at manufacturing facilities on three continents.

The company's own description

Before the merger, Troy described itself as developing and manufacturing "specialty materials that enhance the properties and performance of its customers' products and processes." It also emphasised a commitment to helping manufacturers meet global compliance and sustainability requirements, sales offices across the US, Canada, Europe, Asia and Latin America, and availability in more than 100 countries (Troy boilerplate in Ashland's press release, 1 July 2015).

Arxada's merger announcement (5 January 2022) characterised Troy as a global leader in industrial preservation. It cited expertise in paints and coatings, wood protection and preservation, home and personal care, plastics and textiles, energy, and metalworking fluids, and highlighted Troy's invention of IPBC.

Business and revenue model

DimensionCharacterisation
Revenue modelAlmost entirely product sales (B2B specialty chemicals sold by the kilogram or tonne). Technical services such as microbiological challenge testing, field exposure testing, regulatory support and the "TMMA" microbial management programme are bundled to win and defend specifications rather than billed as material standalone revenue. No subscription or licensing revenue model has been disclosed.
Product vs service mixMostly product. The service share is n/d.
Value chain positionMid-stream. Troy synthesises or formulates active ingredients (notably IPBC) and blends multi-active preservative packages, then sells them to formulators (paint, coatings, adhesives, MWF and personal care manufacturers), who embed them in finished goods at low dosage, typically well under 1% of formulation.
Pricing power driversRegulatory registrations (US EPA FIFRA, EU BPR, GB BPR), long qualification cycles at customers, formulation-specific efficacy data, and a very low share of the customer's bill of materials.
Customer typesArchitectural and industrial paint makers; construction products, adhesives, sealants and grout producers; wood treaters; plastics and textile processors; MWF and lubricant blenders; personal and home care formulators; ink and pigment-dispersion makers; paper producers.
End-marketsPaints and coatings (largest, based on Troy's own emphasis on "architectural coatings and industrial preservation"), building products, wood protection, adhesives and sealants, metalworking fluids and lubricants, plastics, textiles, personal care, inks, paper.

Independent characterisation

Troy is best understood as a regulatory-moat niche chemical franchise. The economic value rests less on manufacturing scale than on its portfolio of registered active substances and the efficacy dossiers supporting them. Re-registering or newly registering a biocidal active in the EU or US can take years and cost millions of dollars per substance. That keeps entry barriers high and the competitor set concentrated. Troy's distinctive asset was IPBC know-how. Arxada stated that it did not manufacture IPBC before the deal (Cinven / Arxada announcement, 3 November 2021). Troy therefore filled a specific gap: dry-film protection for architectural coatings, which complemented Arxada's legacy strength in wet-state preservation (Daryl Smith, Troy CEO, quoted by Lubes'n'Greases, November 2021).

Financial Narrative

Disclosure position

Troy was privately held before 2022 and has published no financial statements. Since January 2022 its results have been consolidated within Arxada (Herens Midco S.à r.l.), whose quarterly and annual reports are distributed only to creditors through a restricted debt-domain portal. The figures below are therefore limited to what Arxada has publicly stated. Every other line item is not publicly disclosed.

Income statement (chartable)

Sources: Arxada boilerplate ("sales of CHF 2 billion in 2024"; "sales of CHF 2billion in 2025"), job postings 2025 and the release of 30 September 2026. Revenue CAGR cannot be computed for a five-year window. The two available data points imply roughly flat revenue between FY2024 and FY2025 on a rounded basis.

Cash flow (chartable)

The CHF 200 million sponsor injection was agreed under the May 2026 TSA. It was implemented in 2026 (FY2026), so it is shown against FY2025 only as the most recent disclosed capital event. Correction for charting: this value belongs to FY2026 and should not be read as an FY2025 cash flow.

Commentary

The only firm conclusions supported by public evidence concern the parent's capital structure, not Troy's own operations.

  1. Top line plateau. Arxada's revenue stayed at about CHF 2 billion in both 2024 and 2025, and its headcount boilerplate slipped from about 3,200 to about 3,100. Together these suggest a flat-volume, cost-control environment.

  2. Balance sheet stress. On 12 May 2026 Arxada announced a recapitalisation built on three elements: CHF 200 million of new sponsor money ranking junior to senior secured debt, an extension at par of about three years (to 2031 for senior secured debt and 2032 for senior unsecured notes), and covenant amendments. The CFO framed the deal as a "proactive step… well ahead of maturities" and referred to visibility "towards cyclical recovery." These are classic markers of a leveraged buyout whose EBITDA undershot underwriting assumptions, most likely through destocking and weaker construction and coatings demand during 2023–2025.

  3. Use of proceeds. Net proceeds repaid drawn revolving credit facility (RCF) loans and bolstered liquidity, which indicates the RCF had been drawn to support liquidity.

  4. Implications for Troy. Troy's architectural-coatings exposure is cyclical, tied to housing turnover and repaint activity. It probably contributed to, rather than offset, the group's softness, but this cannot be quantified from public data.


7. SEGMENTAL AND GEOGRAPHIC REVENUE MAPPING

Disclosure position

No geographic revenue split for Troy or Arxada is publicly available.

Qualitative geographic profile (Troy legacy)

Fastest-growing and declining regions: not publicly disclosed. Troy's pre-merger investment pattern (dedicated India/Asia leadership, China Green Label portfolio, tropical-climate field testing) suggests management saw Asia as the growth market. That is an inference, not a reported result.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Structure

LevelEntityRole

Ultimate owners

Bain Capital Private Equity and Cinven funds, plus reinvested former Troy owners

Equity sponsors

Holding

Herens HoldCo / Herens Midco S.à r.l. (Luxembourg)

Financing and borrowing group ("Arxada")

US holding

Arxada Holdings NA Inc.

Plaintiff entity in the Delaware litigation; US acquisition vehicle

US operating

Arxada LLC; Troy Corporation (legacy legal entity)

Florham Park site; US commercial and manufacturing

International

Legacy Troy subsidiaries in Europe, Asia and Latin America (entity names n/d)

Production and sales

Legacy Troy Family Details

Legacy Troy familyCurrent Arxada solution area (arxada.com navigation)

Polyphase, Fungitrol, Troysan dry-film preservatives

Paints & Coatings; Material Protection

Mergal, Nuosept wet-state preservatives

Paints & Coatings; Material Protection; Home & Personal Care

MWF bactericides, fungicides, test kits

Material Protection (metalworking fluids)

Wood preservation actives (IPBC-based)

Wood Protection

Troykyd, Troysol, Troysperse, Troythix additives

Paints & Coatings

Troymax / Troychem driers and metal carboxylates

Paints & Coatings

Revenue by Segment

Segment (CHF Mn)FY2024FY2025

Arxada group revenue (approx.)

2,0002,000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Brand Details

BrandDescription and capabilitiesTarget customerNamed offeringsLaunch / latest

Polyphase®

IPBC-based and multi-active dry-film fungicides and mildewcides; protects applied coatings against mould and algae

Architectural paint, sealants, caulks, wood coatings

Polyphase P100 (non-metallic fungicide or mildewcide); Polyphase PW40 (China Green Label compliant); Polyphase CR controlled-release fungicide and algaecide

IPBC invented by Troy (year n/d); Polyphase CR showcased 2018

Fungitrol®

Dry-film fungicides acquired from Ashland in 2015

Coatings, construction materials

Specific grades n/d

Acquired 1 July 2015

Troysan®

Dry-film preservative family suited to tropical climates

Coatings in the Asia-Pacific region

Troysan V662 (China Green Label)

Latest grade year n/d

Brand Details — Mergal®

BrandDescriptionTarget customerNamed offerings

Mergal®

Wet-state preservatives with "quick-kill" activity and long-term protection; latest grades free of VOCs, APEs and formaldehyde

Water-based paints, adhesives, polymer emulsions, household products

Mergal K12; Mergal 786 (China Green Label)

Nuosept®

Wet-state preservatives acquired from Ashland in 2015

Coatings, emulsions, adhesives

Nuosept 497G (1,2-benzisothiazolin-3-one, BIT)

Offering Details

OfferingDescriptionTarget customer

MWF bactericides and fungicides

Biocides for aqueous and water-dilutable metalworking fluids, coolants and lubricants

MWF and lubricant blenders (STLE corporate member profile)

Microbial contamination test kits

Field detection kits for fluid contamination

MWF end users and blenders

Technical services

Microbiological challenge testing and global regulatory support

Same

Brand Details — Troykyd®

BrandFunctionNamed offeringsNotes

Troykyd®

Defoamers and air-release additives

D11 (non-silicone, high efficiency); D209W (2016); D727 (silicone-free, multi-hydrophobe); D729 (antifoam / defoamer); D736 (silicone-free); D745 (air release, aqueous systems)

Liquid coatings and inks

Troysol™

Substrate wetting, flow and levelling

ZLAC (multipurpose, silicone-free wetting additive)

—

Troysperse™

Pigment dispersants and wetting additives

CD1 (alkyd-based polymeric dispersant, non-aqueous); W (surfactant plus modified fatty acids); ZWD1 (2016); ZWD "green" aqueous range (2018)

Pigment dispersions

Troythix®

Rheology modifiers

Grades n/d

—

Powder coating additives

Flow, degassing and related functions

Grades n/d

Powder coatings

Brand Details — Troymax™

BrandFunctionNotes

Troymax™

Driers for oxidatively curing coatings

Grades n/d

Troychem™

Driers and anti-skinning additives

Grades n/d

Urethane catalysts and lubricant carboxylates

Catalysis and lubricant additives

Lubes'n'Greases, November 2021

Service Details

ServiceDescription

TMMA microbial management programme

Plant-hygiene and contamination management for customers (ABRAFATI 2017)

Field exposure testing network

Field test sites worldwide, including India, Southeast Asia and elsewhere in Asia, to verify dry-film performance in humid climates

Regulatory affairs support

Registration support across jurisdictions

Product by Date

DateProductRelevance

18 February 2025

Polyboost™ multifunctional additive for paints and coatings

Extends the Troy-derived additives line

13 March 2025

TIME Controlled Release technology showcased at ECS 2025

Builds on the controlled-release dry-film lineage (Polyphase CR)

20 April 2026

New paints and coatings innovations at ACS 2026

Same market (specific products n/d)

Income Statement

MetricFY2024FY2025

Arxada revenue (CHF Mn)

2,0002,000

Balance Sheet

MetricFY2025

Sponsor new-money equity / junior injection (CHF Mn)

200

Financial Analysis

RatioStatus

Net debt / EBITDA

n/d. The need for a sponsor-funded recapitalisation, a maturity extension and covenant amendments implies leverage elevated well above the issuer's original plan. The precise multiple was shared only with creditors.

Key Financials

Region (CHF Mn)FY2024FY2025

Total Arxada

2,0002,000

Region Overview

RegionEvidence of presenceCommercial emphasis

North America

HQ in Florham Park, NJ; manufacturing in Newark, NJ; Canadian sales offices

Home market; architectural coatings, MWF

Latin America

Brazil location (Craft); ABRAFATI participation; VP and GM Americas role

Coatings in Brazil and Argentina

Europe

Manufacturing in Europe (BNP Media, 2018); EU BPR registrations

Coatings, wood protection

Asia

Manufacturing in Asia; active at ChinaCoat and PAINTINDIA; field sites in India and Southeast Asia; a dedicated SVP for "AMEAI" (Asia, Middle East, Africa, India)

Tropical dry-film protection; China Green Label products

Capital Markets

ItemStatus

Share price performance (1/3/5-year)

Not applicable (no listed equity)

Valuation multiples (P/E, EV/EBITDA, EV/Sales, P/B)

Not applicable or n/d

Dividend history and policy

None public (sponsor-owned)

Credit ratings (Moody's / S&P / Fitch)

Arxada's debt is believed to be rated, given its public senior secured and senior unsecured notes, but ratings and outlooks were not confirmed in this research (n/d)

Debt instruments

Senior credit facilities (term loans plus RCF), senior secured notes, fixed-rate senior unsecured notes (Arxada, 12 May 2026)

Debt maturity profile (post-A&E)

Senior secured debt extended to 2031; senior unsecured notes to 2032 (Arxada, May 2026; completed 30 September 2026)

Recent capital injection

CHF 200 million of sponsor new money, junior to senior secured debt

Capital Markets Data

MetricFY2026

Sponsor new money (CHF Mn)

200

Senior secured maturity year after A&E

2031

Senior unsecured maturity year after A&E

2032

Catalyst Details

CatalystWhat to watch

FY2026 results (to creditors, around Q2 2027)

EBITDA trajectory after recapitalisation

Collection of the Harvey judgment

Cash realisation versus paper award

EU BPR and EPA decisions on key actives

Portfolio durability

Coatings demand indicators (US existing-home sales, EU construction)

Volume recovery

Leadership announcements

Permanent CFO after Frauenknecht's move; board changes

Sponsor exit signals

Sale, partial carve-outs (for example, NCE versus Microbial Control), or an IPO

Clorox–Quanticare roll-out

Healthcare growth proof point

Executive Leadership

Executive Leadership Team

NameTitleNotes

Daryl D. Smith

Chairman, President and CEO

Led the sale to Arxada; quoted in the 3 November 2021 announcement

W. Brian Smith

Executive VP and COO

Craft

Ismael Colon

Senior VP, Science and Technology

Craft

Donald A. Shaw

Senior VP, AMEAI and Regulatory Affairs

Craft; PAINTINDIA 2018

David Faherty

VP and GM, Americas

ABRAFATI 2017

Dr. Frank Cangelosi

VP Marketing

ACS 2018

Executive Leadership Team — Peter Frauenknecht

NameTitleTenurePrior roles

Peter Frauenknecht

CEO (as signed on the release of 30 September 2026); previously CFO from 29 November 2022

CFO 2022–2026; CEO date n/d

CFO of Atotech (2017–2022, including its NYSE listing); CFO and executive roles at Constantia Flexibles and OSRAM

Sanjeev Rastogi

CEO from 20 September 2023; President CMC from April 2023

Current status n/d (succeeded by Frauenknecht by September 2026)

SVP Resins at Hexion; VP Fluorine Products at Honeywell

Marc Doyle

Founding CEO (July 2021–September 2023), then non-executive director

Board status n/d

—

Kristin Rinaldi

SVP, General Counsel

Quoted March 2026

—

Rick Strittmatter

Chief Technology, Innovation and Sustainability Officer

Quoted July 2025

—

Eugene Galdi

Chief Procurement Officer

Featured March 2025

—

Annette Bergknut

Chief People Officer

Appointed 25 September 2023

—

Tafa Magaya

SVP Growth, Strategy and Transformation

Appointed 4 December 2023

—

Maëlys Castella

Board member and Audit Committee Chair

Appointed 8 January 2025

—

Directors' Remuneration

ItemDetail

Board composition and independence

n/d (private). Sponsor representatives from Bain and Cinven are expected; the Audit Committee is chaired by Maëlys Castella.

Executive compensation

Not publicly disclosed (no proxy statement)

Equity owners

Bain Capital and Cinven funds (controlling); former Troy owners hold a reinvested minority stake (3 November 2021 announcement). Exact stakes n/d.

Institutional holders (top 10)

Not applicable to equity. Debt holders participating in the 2026 TSA are not individually disclosed.

Insider ownership

Former Troy owners' rollover stake (size n/d)

Governance Detail

ThemeEvidence

"Preservation go-to within specialty chemicals"

Rastogi on appointment, September 2023

Innovation intensity

Patent filings doubled in 2024 (release, 22 January 2025)

Sustainability as a commercial lever

SBTi validation (2023); EcoVadis bronze (2023), silver (2025, top 10%) and gold (June 2026); CDP "B" climate rating (December 2025)

Healthcare disinfection push

Quanticare EPA registration (February 2025); NUGEN HLD-CD (April 2025); Clorox Healthcare agreement (June 2026)

Personal care actives

Geomulse (2024), Geogard NEU (April 2026), Geomulse Cleanse (May 2026)

Paints and coatings innovation (legacy Troy core)

Polyboost (2025); TIME controlled-release technology (2025); ACS 2026 launches

IP enforcement

Delaware trade-secret victory (Enviro Tech founder); AdvanSix settlement; Clean Chemistry suit

Capital structure repair

2026 amend-and-extend with CHF 200 million of sponsor money

Competitive Landscape

Key Competitors

CompetitorOwnership / listingOverlap with Troy portfolio

LANXESS (Material Protection Products)

Listed (Frankfurt)

Industrial biocides, wood and material protection, dry-film actives; expanded via its 2022 purchase of IFF's microbial control business

Thor Group

Private (UK / Germany)

Wet-state and dry-film preservatives (Acticide range) for coatings and construction

Dow / IFF legacy microbial control (now part of LANXESS)

See above

Isothiazolinone-based in-can preservatives

Ashland

Listed (NYSE)

Consumer and personal care preservatives (retained after the 2015 sale to Troy)

Vink Chemicals

Private (Germany)

Biocides for MWF, fuels and coatings

BASF

Listed

Coatings additives (dispersants, defoamers, rheology)

BYK (ALTANA)

Private (ALTANA)

Coatings additives: wetting, dispersing, defoaming, rheology

Evonik (TEGO brands)

Listed

Coatings additives

Borchers (Milliken)

Private

Driers and metal carboxylates; coatings additives

Elementis

Listed (LSE)

Rheology modifiers for coatings

Clariant

Listed (SIX)

Additives and biocide intermediates

Peer Comparison FY2026

DimensionTroy (Arxada)LANXESS MPPThorBYK

Revenue

n/d (parent about CHF 2,000M)

Unit n/d

——

Growth

Flat parent (2024–2025)

———

Positioning

IPBC heritage; dry-film plus wet-state plus additives

Broadest biocide active portfolio after the IFF deal

Coatings-preservation specialist

Additives leader

Recent Developments

All entries are parent-level (Arxada) because Troy no longer issues its own releases.

Company Snapshot

650

Employees

1950

Founded

NJ, US

Headquarters

SWOT Analysis

Strengths

  • Proprietary IPBC heritage: Arxada credits Troy with inventing IPBC and stated that it did not previously make it (3 November 2021)
  • Broad coatings portfolio: More than 400 products across preservatives, additives and carboxylates (Lubes'n'Greases, 2021)
  • Global reach: Products sold in more than 100 countries; five plants on three continents
  • Inorganic capability: Integrated the Ashland industrial biocides lines (2015)
  • Green-compliant grades: VOC-, APE- and formaldehyde-free Mergal; China Green Label products
  • Parent scale and ESG credentials: Arxada: CHF 2 billion sales, 24 plants, 14 R&D centres; EcoVadis Gold (2026)

Weaknesses

  • No financial transparency: No public statements for Troy or Arxada equity
  • Parent leverage: The 2026 A&E needed CHF 200 million of sponsor money and covenant amendments
  • Flat parent revenue: CHF 2 billion in both 2024 and 2025
  • Leadership churn at the parent: Three CEOs in about five years (Doyle, Rastogi, Frauenknecht)
  • Cyclical end-market concentration: Troy's self-described strength is architectural coatings

Opportunities

  • Controlled-release and multifunctional additives: Polyphase CR (2018), TIME technology (2025), Polyboost (2025)
  • Asia growth: PAINTINDIA and ChinaCoat focus; tropical field-testing network
  • Cross-selling into Arxada's wet-state customer base: Stated deal rationale (Daryl Smith, 2021)
  • Cyclical recovery in coatings and housing: CFO cites "visibility towards cyclical recovery" (May 2026)
  • Regulatory scarcity value: Each active lost by competitors raises the value of retained registrations
  • Litigation proceeds: About USD 70 million judgment (March 2026), subject to collection

Threats

  • Regulatory restriction of actives: CTO commentary on "regulatory hurdles" and biocide alternatives (July 2025)
  • Consolidated competitors: LANXESS scale after the IFF acquisition
  • Refinancing risk deferred, not removed: Maturities now 2031 and 2032
  • Talent and trade-secret leakage: Harvey case: defendants built a rival business with misappropriated data
  • Patent disputes: AdvanSix (settled 2025); Clean Chemistry (filed 2025)
  • Sponsor exit pressure: Bain and Cinven have held the business since 2021; an exit could break up the portfolio

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
16 April 2025ISO 9001 recertificationQuality continuity across sites
24 April 2025NUGEN® HLD-CD healthcare disinfectant introducedHealthcare expansion
May 2025CEO Rastogi interview in Paint India on innovation and growthCoatings (legacy Troy) remains strategic
May–June 2025Wood Protection business featured in Manufacturing Today and Timber Trade JournalIPBC-relevant segment profile
23 June 2025Enviro Tech files patent infringement claim against Clean ChemistryIP enforcement
July 2025CTO Rick Strittmatter on biocide regulation and alternatives (European Coatings)Regulatory headwinds acknowledged
14 August 2025AdvanSix and Arxada settle patent suitsRemoves litigation overhang
27 August 2025Lisa Dreilinger joins Green Seal steering committeeStandards influence
23 September 2025Peragreen® 26WW launched for municipal wastewaterWater market
9 October 2025Patented on-site peracetic acid (PAA) generation technology launchedInnovation
13 October 20252024 Sustainability Report releasedESG disclosure
19 December 2025CDP climate rating "B"ESG
7 January 2026Salto (Brazil) site earns Social Seal for the second yearLatin America operations
27 January 2026Enviro Tech launches PD2 poultry litter treatmentAgricultural hygiene
28 January 2026Delaware Chancery decision (Vice Chancellor Laster) awards more than USD 50 million against Harvey defendantsLegal win; deterrent
13 March 2026Final judgment of nearly USD 70 million including exemplary damages and fees (announced 17 March)Potential cash inflow (collectability n/d)
7 April 2026Geogard® NEU launched at in-cosmetics 2026Personal care preservation
20 April 2026Paints and coatings innovations unveiled at ACS 2026Legacy Troy market
12 May 2026TSA signed (about 62% of senior secured, about 55% of all creditors); CHF 200 million sponsor money; FY2025 report released to creditorsMajor capital event
13 May 2026Strong early uptake of Geogard NEU reportedCommercial traction
18 May 2026Geomulse® Cleanse launched at NYSCC; FY2025 creditor call heldPersonal care; investor communication
3 June 2026Clorox Healthcare agreement for Quanticare in HyperOxi wipesValidates healthcare platform
17 June 2026EcoVadis Gold medalESG upgrade (from silver)
22 and 24 June 2026Updates on recapitalisation and TSAProcess progress
6 July 2026Practice statement letter to creditors (scheme route)Signals failure to reach consensual thresholds
28 July 2026Explanatory statement postedScheme formalities
28 August 2026Creditor meetings approve the schemeKey hurdle cleared
3 September 2026Chemical Week feature ("Quantum Leap")Visibility
15 September 2026 (announced 17 September)English High Court sanctions the schemeLegal implementation
30 September 2026Amend-and-extend completed; 100% of participating creditors voted in favour; Frauenknecht named CEOBalance sheet runway to 2031–2032

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

1 chart
Revenue by Segment: Arxada group revenue (approx.) held from CHF 2,000 Mn in FY2024 to CHF 2,000 Mn in FY2025.
Troy Corporation — Revenue by Segment
Series (CHF Mn)FY2024FY2025
Arxada group revenue (approx.)2,0002,000

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.